NCT05009069 2026-04-21
A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer
Hoffmann-La Roche
Phase 2 Active not recruiting
Hoffmann-La Roche
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
Jules Bordet Institute
Blokhin's Russian Cancer Research Center
Memorial Sloan Kettering Cancer Center
Rabin Medical Center
University of Birmingham